Cancer nutrition in China: development and challenges

doi:10.3969/j.issn.1006-7795.2019.02.001

Abstract

Abstract: In China, the incidence of cancer malnutrition is high and it leads to poor clinical outcome, increased complications, extension of hospital stay and shortened survival time. Misunderstanding on cancer nutrition therapy and non-standard treatment restricts the development of cancer nutrition. In recent years, the development of cancer nutrition in China has attracted more attention and made a great progress:①exploring the molecular mechanisms and the individual differences of nutritional metabolism based on the characteristics of tumor metabolism, which provide the basis for individualized nutritional therapy; ②conforming the cancer nutritional status in China:the high incidence of severe malnutrition, lack of nutrition knowledge in patients and medical personnel, improper practice,which is helpful for government policies making and the development of disciplines and clinical treatment;③established the disciplines of cancer nutrition, the diagnosis and treatment system of cancer nutrition in China. Proposed three level diagnosis, four dimensional analysis and five ladder therapy of malnutrition;④Promoting the awareness of cancer nutrition, standardizing diagnosis and treatment,which promote the application and popularity of cancer nutrition care. However, further work is needed to revise the awareness and remedy inappropriate management of cancer nutrition in China. Ultimately it bring nutrition care to the first-line therapy.

Key words: cancer, malnutrition, cancer nutrition

CLC Number:

Shi Hanping, Jia Pingping. Cancer nutrition in China: development and challenges[J]. Journal of Capital Medical University, 2019, 40(2): 159-162.

0
/ / Recommend

Add to citation manager EndNote|Reference Manager|ProCite|BibTeX|RefWorks

URL: https://journal03.magtech.org.cn/Jweb_sdykdxxb/EN/10.3969/j.issn.1006-7795.2019.02.001

https://journal03.magtech.org.cn/Jweb_sdykdxxb/EN/Y2019/V40/I2/159

References

[1] Ottery F D. Rethinking nutritional support of the cancer patient:the new field of nutritional oncology[J]. Semin Oncol, 1994,21(6):770-778.
[2] 张有成,王满才.癌症患者的消瘦问题[J].肿瘤代谢与营养电子杂志,2014,1(1):18-20.
[3] Meijers J M, Halfens R J, Wilson L, et al. Estimating the costs associated with malnutrition in Dutch nursing homes[J].Clin Nutr,2012,31(1):65-68.
[4] Löser C. Malnutrition in hospital:the clinical and economic implications[J].Dtsch Arztebl Int, 2010,107(51-52):911-917.
[5] Freijer K, Nuijten M J, Schols J M. The budget impact of oral nutritional supplements for disease related malnutrition in elderly in the community setting[J]. Front Pharmacol, 2012,3:78.
[6] Philipson T J, Snider J T, Lakdawalla D N, et al. Impact of oral nutritional supplementation on hospital outcomes[J].Am J Manag Care, 2013,19(2):121-128.
[7] 石汉平,杨剑,张艳. 肿瘤患者营养教育[J]. 肿瘤代谢与营养电子杂志,2017,4(1):1-6.
[8] Yuan Y, Liu L, Chen H, et al. Comprehensive characterization of molecular differences in cancer between male and female patients[J]. Cancer Cell, 2016,29(5):711-722.
[9] Fu H, Xu H, Chen H, et al. Inhibition of glycogen synthase kinase 3 ameliorates liver ischemia/reperfusion injury via an energy-dependent mitochondrial mechanism[J].J Hepatol, 2014,61(4):816-824.
[10] Zhang Q, Fu H, Zhang H, et al. Hydrogen sulfide preconditioning protects rat liver against ischemia/reperfusion injury by activating Akt-GSK-3β signaling and inhibiting mitochondrial permeability transition[J]. PLoS One, 2013,8(9):e74422.
[11] Zhang J, Jia P P, Liu Q L, et al. Low ketolytic enzyme levels in tumors predict ketogenic diet responses in cancer cell lines in vitro and in vivo[J]. J Lipid Res, 2018,59(4):625-634.
[12] Wei X, Xu Y, Xu F F, et al. Rel B expression determines the differential effects of ascorbic acid in normal and cancer cells[J].Cancer Res, 2017,77(6):1345-1356.
[13] 石汉平.肿瘤营养石汉平2018观点[M]. 北京:科学技术文献出版社,2018.
[14] 张晓伟,李薇,陈公琰,等. 中国医务人员肿瘤营养知识-态度-行为调查分析[J]. 肿瘤代谢与营养电子杂志,2016,3(2):108-113.
[15] 丛明华,王杰军,方玉,等. 肿瘤内科住院患者膳食认知行为横断面多中心研究[J]. 肿瘤代谢与营养电子杂志,2017,4(1):39-44.
[16] Cong M, Wang J, Fang Y, et al. A multi-center survey on dietary knowledge and behavior among inpatients in oncology department[J]. Support Care Cancer, 2018, 26(7):2285-2292.
[17] 张晓伟,李增宁,石汉平. 医学生营养知识-态度-行为现状调查分析[J]. 中华普通外科学文献(电子版) 2013,7(5):62-64.
[18] 石汉平,赵青川,王昆华,等. 营养不良的三级诊断[J]. 中国癌症防治杂志,2015,7(5):313-319.
[19] 石汉平,许红霞,李苏宜,等. 营养不良的五阶梯治疗[J]. 肿瘤代谢与营养电子杂志,2015,2(1):29-33.
[20] Zhou T, Wang B, Liu H, et al. Development and validation of a clinically applicable score to classify cachexia stages in advanced cancer patients[J]. J Cachexia Sarcopenia Muscle, 2018,9(2):306-314.
[21] 石汉平,李增宁,王昆华,等. 营养管理新模式——HCH[J]. 肿瘤代谢与营养电子杂志,2015,2(3):23-26.
[22] 石汉平. 整体营养疗法[J]. 肿瘤代谢与营养电子杂志,2017,4(2):130-135.
[23] 石汉平. 营养治疗的疗效评价[J]. 肿瘤代谢与营养电子杂志,2017,4(4):364-370.
[24] 石汉平. 肿瘤生酮疗法[J]. 肿瘤代谢与营养电子杂志,2016,3(2):66-70.
[25] 石汉平. 肿瘤新疗法——代谢调节治疗[J]. 肿瘤代谢与营养电子杂志,2014,1(1):3-5.
[26] 石汉平. 肿瘤营养疗法[J]. 中国肿瘤临床,2014,41(18):1141-1145.
[27] Shi H P. Discipline of nutritional oncology:principle, theory, practice and perspectives[J]. J Nutr Oncol,2017,2(1):1-6.
[28] 石汉平,凌文华,李薇.肿瘤营养学[M].北京:人民卫生出版社,2012.
[29] 石汉平,李薇,齐玉梅,等.营养筛查与评估[M].北京:人民卫生出版社,2014.
[30] 石汉平,李薇,陈公琰,等.肿瘤恶液质[M].北京:人民卫生出版社,2015.
[31] 石汉平,崔久嵬.肿瘤免疫营养[M].北京:人民卫生出版社,2018.
[32] 中国抗癌协会. WS/T 555-2017肿瘤患者主观整体营养评估[S].
[33] 石汉平,陈伟,杨柳青,等. 建设"无饿医院"[J]. 肿瘤代谢与营养电子杂志,2018,5(3):225-230.
[34] 吕家华,李涛,朱广迎,等.食管癌同步放化疗联合肠内营养治疗前瞻性多中心随机对照临床研究中期结果报告[J]. 肿瘤代谢与营养电子杂志,2016,3(4):239-242.
[35] Hu C L, Yu M, Yuan K T, et al. Determinants and nutritional assessment value of hand grip strength in patients hospitalized with cancer[J]. Asia Pac J Clin Nutr, 2018,27(4):777-784.
[36] Yu J M, Yang M, Xu H X, et al. Association between serum c-reactive protein concentration and nutritional status of malignant tumor patients[J]. Nutr Cancer, 2018,1-6.
[37] 石汉平,江华,李薇,等. 中国肿瘤营养治疗指南[M].北京:人民卫生出版社,2015.
[38] Lyu J, Li T, Xie C, et al. China society for nutritional oncology. Enteral nutrition in esophageal cancer patients treated with radiotherapy:a Chinese expert consensus 2018[J]. Future Oncol, 2018, 2019,15(5):517-531.
[39] 李增宁,陈伟,齐玉梅,等. 恶性肿瘤患者膳食营养处方专家共识[J]. 肿瘤代谢与营养电子杂志,2017,4(4):397-408.